Jonathan Ferrand PhD
Chief Scientific Officer
Jonathan has more than a decade of laboratory experience in immunology, oncology and clinical bioanalysis. He holds a PhD from the University of Bordeaux and completed postdoctoral research investigating inflammatory pathways in infection and cancer.
As Chief Scientific Officer, Jonathan leads Crux Biolabs’ scientific direction across all scientific teams, supporting the development and delivery of fit-for-purpose bioanalytical solutions for clinical research programs. His experience includes pharmacokinetic and pharmacodynamic assay development and validation for clinical research programs.
